Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Decision support at the point of prescribing to increase formulary adherence
Pieter J Helmons1, Carrie R Coates2, Jos G W Kosterink2
1Pieter J. Helmons, Pharm.D., Ph.D., M.A.S., is Hospital Pharmacist, St. Jansdal Hospital, Harderwijk, Netherlands; at the time of the study described herein, he was Pharmacist-Specialist in Pharmacoeconomics, University of California San Diego (UCSD) Health System, San Diego. Carrie R. Coates, Pharm.D., is Informatics Pharmacist, Department of Pharmacy, UCSD Health System. Jos G. W. Kosterink, Ph.D., Pharm.D., is Hospital Pharmacist and Clinical Pharmacologist, Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. Charles E. Daniels, Ph.D., B.S.Pharm., is Professor of Clinical Pharmacy and Associate Dean for Clinical Affairs, UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, and Pharmacist-in-Chief, Department of Pharmacy, UCSD Health System. pj.helmons@stjansdal.nl.
Purpose:
Study results demonstrating the effectiveness of order-entry clinical decision support (CDS) alerts as a tool for enforcing therapeutic interchange are presented.
Methods:
A retrospective observational study was conducted at an academic medical center to evaluate formulary nonadherence before and after implementation of a fully electronic medical record with computerized prescriber order-entry (CPOE) technology configured to display therapeutic interchange alerts immediately on entry of orders for nonformulary agents. Formulary nonadherence (defined as the proportion of pharmacist-verified nonformulary orders to total verified orders) within eight medication classes was assessed during a six-month baseline period and two consecutive six-month periods after implementation.
Results:
In the 12 months after implementation of the therapeutic interchange alerts, the overall rate of formulary nonadherence decreased by 65%, from 3.5% at baseline to 1.2% during the second 6-month postintervention period (p < 0.001). The total number of verified nonformulary orders decreased from 300 at baseline to 102 during the second postintervention period. The largest decreases in formulary nonadherence were observed in the intranasal steroid drug class (the rate of nonadherent orders declined by a total of 12 percentage points) and the nonbarbiturate sedatives and hypnotics class (a 5-point decline), with significant 6- and 12-month declines also documented in four of the remaining six drug classes.
Conclusion:
The incorporation of hard-stop CDS alerts into the CPOE system improved the overall rate of prescriber adherence to institutional therapeutic interchange protocols.
Related Concept Videos
Oral Drug Delivery Systems: Introduction
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Oral Drug Delivery Systems: Continuous-Release Systems

